×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
5268 views

Moderators : Anna Fagotti & Gwenaël Ferron

Agenda

  Introduction
Anna Fagotti & Gwenaël Ferron
 
  HIPEC in first setting
Willemien Van Driel
 
  HIPEC in recurrent disease
Jean-Marc Classe
 
  Oncologic issues
Laurence Gladieff
 
  Take home message
Anna Fagotti
 

 

Shooting date : 2024-02-06
Last update : 2024-04-03
2 comments
Join the Discussion
  • ANIK G. Can't wait to see this webinar. Wonderful and much anticipated topic.

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • Gwenaël F. Dear Anik. The VOD is available !!

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      Suggestions

      Monday, October 4th 2021 from 06pm to 07:30pm (GMT+2)
      Honolulu : Monday, October 4th 2021 from 06am to 07:30am (GMT-10)
      San Francisco : Monday, October 4th 2021 from 09am to 10:30am (GMT-7)
      New York : Monday, October 4th 2021 from 12pm to 01:30pm (GMT-4)
      Buenos Aires : Monday, October 4th 2021 from 01pm to 02:30pm (GMT-3)
      Reykjavik : Monday, October 4th 2021 from 04pm to 05:30pm (GMT)
      London / Dublin : Monday, October 4th 2021 from 05pm to 06:30pm (GMT+1)
      Paris / Berlin : Monday, October 4th 2021 from 06pm to 07:30pm (GMT+2)
      Istanbul : Monday, October 4th 2021 from 07pm to 08:30pm (GMT+3)
      Moscou / Dubaï : Monday, October 4th 2021 from 08pm to 09:30pm (GMT+4)
      Bangkok : Monday, October 4th 2021 from 11pm to 12:30am (GMT+7)
      Shanghai : Tuesday, October 5th 2021 from 12am to 01:30am (GMT+8)
      Tokyo : Tuesday, October 5th 2021 from 01am to 02:30am (GMT+9)
      Sydney : Tuesday, October 5th 2021 from 03am to 04:30am (GMT+11)
      Wellington : Tuesday, October 5th 2021 from 05am to 06:30am (GMT+13)

      Cancer de l'ovaire : observance long terme sous inhibiteurs de PARP

      Episode 1

      Share
      Monday, November 28th 2022 from 06pm to 07:30pm (GMT+2)
      Honolulu : Monday, November 28th 2022 from 06am to 07:30am (GMT-10)
      San Francisco : Monday, November 28th 2022 from 08am to 09:30am (GMT-8)
      New York : Monday, November 28th 2022 from 11am to 12:30pm (GMT-5)
      Buenos Aires : Monday, November 28th 2022 from 01pm to 02:30pm (GMT-3)
      London / Dublin : Monday, November 28th 2022 from 04pm to 05:30pm (GMT)
      Paris / Berlin : Monday, November 28th 2022 from 05pm to 06:30pm (GMT+1)
      Istanbul : Monday, November 28th 2022 from 06pm to 07:30pm (GMT+2)
      Moscou / Dubaï : Monday, November 28th 2022 from 08pm to 09:30pm (GMT+4)
      Bangkok : Monday, November 28th 2022 from 11pm to 12:30am (GMT+7)
      Shanghai : Tuesday, November 29th 2022 from 12am to 01:30am (GMT+8)
      Tokyo : Tuesday, November 29th 2022 from 01am to 02:30am (GMT+9)
      Sydney : Tuesday, November 29th 2022 from 02am to 03:30am (GMT+10)
      Wellington : Tuesday, November 29th 2022 from 04am to 05:30am (GMT+12)

      Prise en charge du cancer de l’ovaire avancé à l’ère de la médecine de précision en 2022

      Share
      Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+2)
      Honolulu : Wednesday, February 7th 2024 from 06am to 07:30am (GMT-10)
      San Francisco : Wednesday, February 7th 2024 from 08am to 09:30am (GMT-8)
      New York : Wednesday, February 7th 2024 from 11am to 12:30pm (GMT-5)
      Buenos Aires : Wednesday, February 7th 2024 from 01pm to 02:30pm (GMT-3)
      London / Dublin : Wednesday, February 7th 2024 from 04pm to 05:30pm (GMT)
      Paris / Berlin : Wednesday, February 7th 2024 from 05pm to 06:30pm (GMT+1)
      Istanbul : Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+2)
      Moscou / Dubaï : Wednesday, February 7th 2024 from 08pm to 09:30pm (GMT+4)
      Bangkok : Wednesday, February 7th 2024 from 11pm to 12:30am (GMT+7)
      Shanghai : Thursday, February 8th 2024 from 12am to 01:30am (GMT+8)
      Tokyo : Thursday, February 8th 2024 from 01am to 02:30am (GMT+9)
      Sydney : Thursday, February 8th 2024 from 02am to 03:30am (GMT+10)
      Wellington : Thursday, February 8th 2024 from 04am to 05:30am (GMT+12)

      Toxicités hématologiques des inhibiteurs de PARP

      Regards croisés oncologue-hématologue-interniste

      Share
      Wednesday, March 20th 2024 from 07pm to 08pm (GMT+2)
      Honolulu : Wednesday, March 20th 2024 from 07am to 08am (GMT-10)
      San Francisco : Wednesday, March 20th 2024 from 09am to 10am (GMT-8)
      New York : Wednesday, March 20th 2024 from 12pm to 01pm (GMT-5)
      Buenos Aires : Wednesday, March 20th 2024 from 02pm to 03pm (GMT-3)
      London / Dublin : Wednesday, March 20th 2024 from 05pm to 06pm (GMT)
      Paris / Berlin : Wednesday, March 20th 2024 from 06pm to 07pm (GMT+1)
      Istanbul : Wednesday, March 20th 2024 from 07pm to 08pm (GMT+2)
      Moscou / Dubaï : Wednesday, March 20th 2024 from 09pm to 10pm (GMT+4)
      Bangkok : Thursday, March 21st 2024 from 12am to 01am (GMT+7)
      Shanghai : Thursday, March 21st 2024 from 01am to 02am (GMT+8)
      Tokyo : Thursday, March 21st 2024 from 02am to 03am (GMT+9)
      Sydney : Thursday, March 21st 2024 from 03am to 04am (GMT+10)
      Wellington : Thursday, March 21st 2024 from 05am to 06am (GMT+12)

      Immunothérapies et inhibiteurs de PARP dans la prise en charge du cancer de l’endomètre avancé ...

      éclairages du congrès de la SGO

      Share
      Scroll Up